Evidence map›Paper›PMID 41098152›Full record

ArticleEJHaem2025

Uncommon Evolution From Acute Myeloid Leukaemia to

Mark Anthony Turingan, Ehsan Bahrami Hezaveh, Cuihong Wei, Verna Cheung, Dawn Maze, Hong Chang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mark Anthony TuringanDepartment of Laboratory Hematology and Laboratory Medicine University Health Network Toronto Canada.
Ehsan Bahrami HezavehDepartment of Laboratory Hematology and Laboratory Medicine University Health Network Toronto Canada.
Cuihong WeiDepartment of Biostatistics University Health Network Toronto Canada.
Verna CheungDepartment of Clinical Laboratory Genetics Genome Diagnostics University Health Network Toronto Canada.ORCID https://orcid.org/0000-0002-4921-8102
Dawn MazeDepartment of Clinical Laboratory Genetics Genome Diagnostics University Health Network Toronto Canada.ORCID https://orcid.org/0000-0002-4598-9380
Hong ChangDepartment of Laboratory Hematology and Laboratory Medicine University Health Network Toronto Canada.ORCID https://orcid.org/0000-0003-3106-2776

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The emergence of Case Description: This case series describes two patients who developed Pathogenetic Insight: Findings support clonal persistence from a shared haematopoietic progenitor with divergent progression into distinct myeloid neoplasms. A two-pathway model is proposed to explain this trajectory. Implications: These observations highlight the biological relevance of CHIP-associated mutations and underscore the value of post-remission molecular surveillance to detect emerging secondary neoplasms in AML survivors.

Identifiers

PMID41098152
PMCPMC12519878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.